https://diabetespumps.com/ 2018-01-02T19:04:28+00:00 https://diabetespumps.com/hello-world/ 2017-11-28T05:30:07+00:00 https://diabetespumps.com/wedbush-reconfirms-41-0-pt-on-m-i-homes-nysemho-reconfirms-outperform-rating/ 2018-01-01T09:03:05+00:00 https://diabetespumps.com/becton-dickinson-bdx-buy-rating-reiterated-at-deutsche-bank-with-260-0-target/ 2018-01-01T09:03:10+00:00 https://diabetespumps.com/century-communities-nyseccs-investors-wedbush-maintains-outperform-rating-sees-42-0-share/ 2018-01-01T09:03:22+00:00 https://diabetespumps.com/analog-devices-nasdaqadi-buy-rating-maintained-by-analysts-at-stifel-the-target-price-per-share-given-is-100-0/ 2018-01-01T09:03:42+00:00 https://diabetespumps.com/syntel-nasdaqsynt-lowered-at-wells-fargo-to-underperform-from-market-perform-rating/ 2018-01-01T09:03:47+00:00 https://diabetespumps.com/lennar-nyselen-investors-wedbush-keeps-neutral-rating-sees-60-0-share/ 2018-01-01T11:02:37+00:00 https://diabetespumps.com/pultegroup-nysephm-neutral-rating-reconfirmed-by-wedbush-the-target-is-35-0/ 2018-01-01T11:03:08+00:00 https://diabetespumps.com/wedbush-reconfirms-30-0-target-price-per-share-on-kb-home-nysekbh-reconfirms-neutral-rating/ 2018-01-01T15:03:33+00:00 https://diabetespumps.com/11-71-to-target-wedbush-reiterates-neutral-rating-for-william-lyon-homes-nysewlh-stock/ 2018-01-01T15:03:46+00:00 https://diabetespumps.com/new-york-cirrus-logic-nasdaqcruss-stock-had-its-buy-rating-restated-at-stifel-in-report-issued-today-has-75-0-target/ 2018-01-01T17:02:59+00:00 https://diabetespumps.com/calatlantic-group-nysecaa-stock-neutral-rating-maintained-at-wedbush-the-tp-is-53-0/ 2018-01-01T17:03:23+00:00 https://diabetespumps.com/18-48-to-target-mkm-partners-keeps-buy-rating-for-adtran-adtn-stock/ 2018-01-01T17:03:37+00:00 https://diabetespumps.com/17-19-to-target-wedbush-reaffirms-outperform-rating-for-tri-pointe-homes-nysetph-stock/ 2018-01-01T18:58:19+00:00 https://diabetespumps.com/new-york-toll-brothers-inc-nysetols-stock-had-its-neutral-rating-restated-at-wedbush-in-report-issued-today-has-47-00-target/ 2018-01-01T18:58:24+00:00 https://diabetespumps.com/analysts-at-wells-fargo-cut-syntel-synt-nysesynt-from-market-perform-to-underperform-rating/ 2018-01-01T18:58:30+00:00 https://diabetespumps.com/jp-morgan-maintains-a-overweight-rating-on-roche-holdings-pkrhhby/ 2018-01-01T18:58:35+00:00 https://diabetespumps.com/realpage-ndaqrp-stock-overweight-rating-reiterated-at-stephens-the-price-objective-is-set-to-54-00/ 2018-01-01T18:58:41+00:00 https://diabetespumps.com/power-integrations-nysepowi-buy-rating-maintained-at-stifel-nicolaus-with-88-00-target/ 2018-01-01T18:58:47+00:00 https://diabetespumps.com/hovde-group-reconfirms-investar-ndaqistr-as-outperform-has-tp-of-28-00/ 2018-01-01T18:58:53+00:00 https://diabetespumps.com/research-analysts-at-stifel-nicolaus-reiterated-their-buy-rating-for-cirrus-logic-ndaqcrus-the-target-price-is-set-to-75-00/ 2018-01-01T18:58:58+00:00 https://diabetespumps.com/astrazeneca-plc-adr-nyseazn-wins-overweight-rating-for-neutral-from-jp-morgan/ 2018-01-01T18:59:03+00:00 https://diabetespumps.com/analysts-at-stifel-nicolaus-maintain-their-buy-rating-for-analog-devices-adi-nyseadi-with-100-00-price-target/ 2018-01-01T18:59:09+00:00 https://diabetespumps.com/adtran-inc-ndaqadtn-stock-rating-reconfirmed-by-analysts-at-mkm-partners-the-25-00-target-indicates-32-07-potential/ 2018-01-01T18:59:14+00:00 https://diabetespumps.com/merus-mrus-downgraded-by-rbc-capital-to-sector-perform-from-outperform-rating/ 2018-01-02T09:06:14+00:00 https://diabetespumps.com/eu-enanta-pharmaceuticals-enta-rating-decreased-to-sector-perform-at-rbc-capital-lost-its-outperform-rating/ 2018-01-02T09:06:30+00:00 https://diabetespumps.com/statoil-asa-sto-wins-outperform-rating-for-sector-perform-from-rbc-capital/ 2018-01-02T09:06:45+00:00 https://diabetespumps.com/new-york-incyte-nasdaqincy-rating-outlook-improved-to-outperform-at-rbc-capital-lost-its-sector-perform-rating/ 2018-01-02T09:07:06+00:00 https://diabetespumps.com/biocryst-pharma-nasdaqbcrx-was-increased-at-rbc-capital-from-a-sector-perform-rating-to-outperform/ 2018-01-02T09:07:22+00:00 https://diabetespumps.com/eu-l-brands-lb-rating-upgraded-to-outperform-by-robert-w-baird-keeping-70-0-tp-lost-its-neutral-rating/ 2018-01-02T11:02:38+00:00 https://diabetespumps.com/washington-reit-wre-was-given-sell-rating-by-stifel-lost-its-hold-rating-the-target-price-per-share-is-still-28-0/ 2018-01-02T11:02:54+00:00 https://diabetespumps.com/needham-reconfirms-88-0-target-price-per-share-on-cvs-health-cvs-reconfirms-buy-rating/ 2018-01-02T11:03:11+00:00 https://diabetespumps.com/merus-nasdaqmrus-rating-lowered-at-rbc-capital-to-sector-perform/ 2018-01-02T11:03:22+00:00 https://diabetespumps.com/rbc-capital-upgrades-incyte-incy-to-outperform-from-sector-perform-rating/ 2018-01-02T11:03:27+00:00 https://diabetespumps.com/dunkin-brands-dnkn-investors-maxim-group-reaffirms-buy-rating-sees-71-0-share/ 2018-01-02T11:03:42+00:00 https://diabetespumps.com/eu-prosperity-bancshares-pb-stock-rating-cut-to-underperform-by-analysts-at-hovde-group-having-68-0-target-lost-its-previous-market-perform-rating/ 2018-01-02T11:03:57+00:00 https://diabetespumps.com/19-83-to-target-btig-maintains-buy-rating-for-mcdonalds-mcd-stock/ 2018-01-02T11:04:15+00:00 https://diabetespumps.com/lamb-weston-lw-investors-stifel-reaffirms-hold-rating-sees-58-0-share/ 2018-01-02T11:04:31+00:00 https://diabetespumps.com/eu-asos-asomf-rating-upped-to-buy-by-deutsche-bank-lost-its-hold-rating/ 2018-01-02T11:04:48+00:00 https://diabetespumps.com/biocryst-pharma-bcrx-increased-by-analysts-at-rbc-capital-to-sector-perform-from-sector-perform-rating/ 2018-01-02T11:04:53+00:00 https://diabetespumps.com/11-03-to-target-benchmark-reconfirms-buy-rating-for-progress-software-prgs-stock/ 2018-01-02T13:02:41+00:00 https://diabetespumps.com/new-york-washington-reit-nysewre-rating-outlook-cut-to-sell-at-stifel-having-28-0-target-price-lost-its-hold-rating/ 2018-01-02T13:02:54+00:00 https://diabetespumps.com/xpo-logistics-xpo-buy-rating-maintained-at-stifel-the-target-price-is-120-0/ 2018-01-02T13:03:15+00:00 https://diabetespumps.com/keybanc-analyst-reaffirmed-38-0-price-target-on-att-t-stock-while-reiterating-sector-weight-rating/ 2018-01-02T13:03:39+00:00 https://diabetespumps.com/verizon-vz-sector-weight-rating-reiterated-at-keybanc-the-tp-given-is-53-0/ 2018-01-02T13:03:54+00:00 https://diabetespumps.com/netflix-nflx-buy-rating-reaffirmed-by-analysts-at-loop-capital-with-241-0-target/ 2018-01-02T13:04:12+00:00 https://diabetespumps.com/equity-research-analysts-at-keybanc-reiterate-their-underweight-rating-for-sprint-s-the-price-objective-given-is-5-0/ 2018-01-02T13:04:28+00:00 https://diabetespumps.com/urogen-pharma-urgns-target-is-50-0-after-initiated-coverage-by-ladenburg-thalmann/ 2018-01-02T13:04:44+00:00 https://diabetespumps.com/leerink-partners-starts-coverage-on-quanterix-qtrx-stock-with-outperform-rating-and-27-0-target/ 2018-01-02T13:04:58+00:00 https://diabetespumps.com/quanterix-qtrx-now-covered-by-equity-analysts-at-jpmorgan-it-got-overweight-rating/ 2018-01-02T13:05:02+00:00 https://diabetespumps.com/odonate-therapeutics-odt-coverage-initiated-by-goldman-sachs-the-firms-target-is-27-0/ 2018-01-02T13:05:18+00:00 https://diabetespumps.com/jefferies-has-started-odonate-therapeutics-nasdaqodt-stock-coverage-with-a-buy-rating-and-target-price-per-share-of-40-0/ 2018-01-02T13:05:36+00:00 https://diabetespumps.com/guggenheim-initiates-nextera-energy-partners-nep-coverage-with-buy-rating-and-45-0-target-price-per-share/ 2018-01-02T13:05:52+00:00 https://diabetespumps.com/luther-burbank-lbc-now-covered-by-equity-analysts-at-sandler-oneill-it-got-hold-rating/ 2018-01-02T13:06:07+00:00 https://diabetespumps.com/octafinance-looks-at-why-the-equity-research-analysts-at-piper-jaffray-started-coverage-on-luther-burbank-lbc-with-neutral-rating-and-price-target-of-14-0/ 2018-01-02T13:06:11+00:00 https://diabetespumps.com/jpmorgan-starts-fgl-holdings-fg-coverage-with-neutral-rating/ 2018-01-02T13:06:28+00:00 https://diabetespumps.com/denali-therapeutics-nasdaqdnli-coverage-started-by-analysts-at-evercore-isi-the-firms-target-price-is-23-0/ 2018-01-02T13:06:50+00:00 https://diabetespumps.com/denali-therapeutics-dnli-coverage-started-by-jpmorgan-the-firms-pt-is-24-0/ 2018-01-02T13:06:53+00:00 https://diabetespumps.com/goldman-sachs-initiates-coverage-on-denali-therapeutics-nasdaqdnli-with-neutral-and-with-19-0-target/ 2018-01-02T13:06:59+00:00 https://diabetespumps.com/morgan-stanley-has-started-coverage-on-denali-therapeutics-nasdaqdnli-stock-with-overweight-rating/ 2018-01-02T13:07:04+00:00 https://diabetespumps.com/curo-group-curo-stock-stephens-has-started-coverage-with-overweight-outlook/ 2018-01-02T13:07:20+00:00 https://diabetespumps.com/curo-group-curo-%e2%88%9e-upside-potential-indicated-by-credit-suisses-target/ 2018-01-02T13:07:24+00:00 https://diabetespumps.com/curo-group-curo-%e2%88%9e-upside-potential-indicated-by-jefferiess-target/ 2018-01-02T13:07:28+00:00 https://diabetespumps.com/william-blair-has-initiated-curo-group-curo-coverage-with-outperform-rating/ 2018-01-02T13:07:32+00:00 https://diabetespumps.com/citigroup-starts-bitauto-holdings-bita-coverage-with-buy-rating/ 2018-01-02T13:07:46+00:00 https://diabetespumps.com/autohome-athm-is-now-covered-by-research-analysts-at-citigroup-they-set-a-buy-rating-on-the-stock/ 2018-01-02T13:08:01+00:00 https://diabetespumps.com/windstream-win-downgraded-at-jpmorgan-to-underweight-from-neutral-rating/ 2018-01-02T13:08:17+00:00 https://diabetespumps.com/eu-viacom-viab-rating-outlook-cut-to-underperform-by-macquarie-lost-its-neutral-rating/ 2018-01-02T13:08:32+00:00 https://diabetespumps.com/guggenheim-decreases-vectren-vvc-rating-to-neutral-from-buy/ 2018-01-02T13:08:47+00:00 https://diabetespumps.com/sucampo-pharma-scmp-lowered-by-leerink-partners-to-mkt-perform-from-outperform-rating/ 2018-01-02T13:09:02+00:00 https://diabetespumps.com/how-will-smart-sand-nasdaqsnd-stock-react-to-janney-capitals-downgrade-to-neutral-from-buy/ 2018-01-02T13:09:20+00:00 https://diabetespumps.com/analysts-at-jpmorgan-cut-sirius-xm-radio-siri-from-neutral-to-underweight-rating/ 2018-01-02T13:09:35+00:00 https://diabetespumps.com/eu-silgan-holdings-slgn-rating-lowered-to-underperform-by-analysts-at-bofa-merrill-lost-its-neutral-rating/ 2018-01-02T13:09:50+00:00 https://diabetespumps.com/royal-bank-of-scotland-rbs-rating-outlook-decreased-by-bernstein-to-mkt-perform/ 2018-01-02T13:10:05+00:00 https://diabetespumps.com/planet-fitness-nyseplnt-was-cut-by-jefferies-from-a-buy-rating-to-hold-one/ 2018-01-02T13:10:22+00:00 https://diabetespumps.com/analysts-at-guggenheim-cut-pge-pcg-from-neutral-to-sell-rating/ 2018-01-02T13:10:36+00:00 https://diabetespumps.com/pge-pcg-rating-lowered-to-neutral-by-goldman-sachs-from-buy/ 2018-01-02T13:10:39+00:00 https://diabetespumps.com/morgan-stanley-downgrades-petrochina-ptr-to-equal-weight-from-overweight-stock-rating/ 2018-01-02T13:10:54+00:00 https://diabetespumps.com/jpmorgan-downgrades-penumbra-pen-to-neutral-from-overweight-stock-rating/ 2018-01-02T13:11:10+00:00 https://diabetespumps.com/omnicom-omc-was-cut-by-analysts-at-macquarie-to-a-underperform-rating/ 2018-01-02T13:11:26+00:00 https://diabetespumps.com/researchers-at-guggenheim-cut-nw-natural-gas-nwn-from-neutral-to-sell-rating/ 2018-01-02T13:11:41+00:00 https://diabetespumps.com/will-macquarie-downgrade-to-neutral-from-outperform-be-a-headwind-for-nielsen-nlsn-stock-today/ 2018-01-02T13:11:55+00:00 https://diabetespumps.com/lululemon-athletica-lulu-decreased-by-analysts-at-citigroup-to-neutral-from-buy-rating/ 2018-01-02T13:12:10+00:00 https://diabetespumps.com/kb-home-kbh-stock-lowered-by-citigroup-to-sell/ 2018-01-02T13:12:26+00:00 https://diabetespumps.com/jones-energy-jone-stock-rating-decreased-by-analysts-at-suntrust-to-hold/ 2018-01-02T13:12:41+00:00 https://diabetespumps.com/equity-analysts-at-jpmorgan-lowered-johnson-johnson-jnj-from-overweight-to-neutral-rating/ 2018-01-02T13:12:56+00:00 https://diabetespumps.com/interpublic-ipg-was-cut-at-macquarie-from-a-neutral-rating-to-underperform-one/ 2018-01-02T13:13:12+00:00 https://diabetespumps.com/integra-iart-losses-buy-rating-from-bofa-merrill-for-neutral/ 2018-01-02T13:13:29+00:00 https://diabetespumps.com/hill-rom-hrc-decreased-by-morgan-stanley-to-equal-weight-from-overweight-rating/ 2018-01-02T13:13:43+00:00 https://diabetespumps.com/jpmorgan-lowers-endologix-elgx-to-underweight-from-neutral-stock-rating/ 2018-01-02T13:13:58+00:00 https://diabetespumps.com/will-jpmorgan-downgrade-to-neutral-from-overweight-be-a-headwind-for-edwards-lifesciences-ew-stock-today/ 2018-01-02T13:14:14+00:00 https://diabetespumps.com/analysts-at-jefferies-downgraded-deckers-outdoor-deck-from-buy-to-hold-rating/ 2018-01-02T13:14:29+00:00 https://diabetespumps.com/conformis-cfms-was-downgraded-by-analysts-at-jpmorgan-from-a-neutral-rating-to-underweight-rating/ 2018-01-02T13:14:44+00:00 https://diabetespumps.com/cbs-cbs-losses-outperform-rating-from-macquarie-for-neutral/ 2018-01-02T13:14:58+00:00 https://diabetespumps.com/new-york-cabot-oil-gas-nysecog-rating-outlook-cut-to-underperform-by-analysts-at-raymond-james-lost-its-outperform-rating/ 2018-01-02T13:15:15+00:00 https://diabetespumps.com/brighthouse-financial-bhf-downgraded-by-analysts-at-jpmorgan-to-underweight-from-neutral-rating/ 2018-01-02T13:15:30+00:00 https://diabetespumps.com/bmw-group-bmwyy-given-a-in-line-rating-by-analysts-at-evercore-isi-lost-its-outperform-rating/ 2018-01-02T13:15:45+00:00 https://diabetespumps.com/bemis-bms-given-a-underperform-rating-by-bofa-merrill-lost-its-neutral-rating/ 2018-01-02T13:16:01+00:00 https://diabetespumps.com/analysts-at-guggenheim-lowered-american-water-works-awk-from-buy-to-neutral-rating/ 2018-01-02T13:16:18+00:00 https://diabetespumps.com/how-will-american-electric-aep-stock-react-to-guggenheims-downgrade-to-sell-from-neutral/ 2018-01-02T13:16:33+00:00 https://diabetespumps.com/amc-networks-amcx-rating-outlook-downgraded-to-neutral-at-macquarie-from-outperform/ 2018-01-02T13:16:47+00:00 https://diabetespumps.com/walt-disney-dis-was-upgraded-by-analysts-at-macquarie-from-a-neutral-rating-to-outperform-one/ 2018-01-02T13:17:16+00:00 https://diabetespumps.com/titan-machinery-titn-upgraded-by-william-blair-to-underperform-from-underperform-rating/ 2018-01-02T13:17:30+00:00 https://diabetespumps.com/timken-tkr-given-the-better-buy-rating-by-analysts-at-longbow-research-no-longer-has-neutral-rating/ 2018-01-02T13:17:46+00:00 https://diabetespumps.com/evercore-isi-upgrades-teradyne-ter-rating-to-outperform-from-in-line/ 2018-01-02T13:18:00+00:00 https://diabetespumps.com/taylor-morrison-home-tmhc-was-improved-at-citigroup-from-a-neutral-rating-to-buy-one/ 2018-01-02T13:18:16+00:00 https://diabetespumps.com/stryker-syk-wins-overweight-rating-for-neutral-from-jpmorgan/ 2018-01-02T13:18:31+00:00 https://diabetespumps.com/will-bofa-merrill-upgrade-to-neutral-from-underperform-be-a-tailwind-for-potlatch-pch-stock-today/ 2018-01-02T13:18:46+00:00 https://diabetespumps.com/posco-pkx-given-the-better-buy-rating-by-analysts-at-goldman-sachs-no-longer-has-neutral-rating/ 2018-01-02T13:19:01+00:00 https://diabetespumps.com/sidoti-upgrades-plantronics-plt-rating-to-buy-from-neutral/ 2018-01-02T13:19:16+00:00 https://diabetespumps.com/paccar-pcar-was-improved-at-bofa-merrill-from-a-neutral-rating-to-buy/ 2018-01-02T13:19:30+00:00 https://diabetespumps.com/nrg-yield-nyld-upped-by-analysts-at-guggenheim-to-neutral-from-neutral-rating/ 2018-01-02T13:19:45+00:00 https://diabetespumps.com/analysts-at-jpmorgan-upgraded-nordstrom-jwn-from-underweight-to-neutral-rating/ 2018-01-02T13:20:00+00:00 https://diabetespumps.com/netflix-nflx-increased-to-outperform-rating-at-macquarie-from-neutral/ 2018-01-02T13:20:04+00:00 https://diabetespumps.com/sidoti-upgrades-national-fuel-gas-nfg-to-buy-from-neutral-rating/ 2018-01-02T13:20:21+00:00 https://diabetespumps.com/medtronic-mdt-was-upgraded-by-analysts-at-bofa-merrill-from-a-neutral-rating-to-buy/ 2018-01-02T13:20:37+00:00 https://diabetespumps.com/lincoln-national-lnc-overweight-rating-by-jpmorgan-from-neutral/ 2018-01-02T13:20:52+00:00 https://diabetespumps.com/lennar-len-rating-was-increased-by-analysts-at-wells-fargo-to-a-outperform-rating/ 2018-01-02T13:21:08+00:00 https://diabetespumps.com/intl-paper-ip-upped-at-bofa-merrill-to-neutral-from-neutral-rating/ 2018-01-02T13:21:23+00:00 https://diabetespumps.com/intl-consolidated-airlines-icagy-increased-at-bofa-merrill-to-underperform-from-underperform-rating/ 2018-01-02T13:21:38+00:00 https://diabetespumps.com/eu-intersect-ent-xent-rating-outlook-upgraded-to-overweight-at-jpmorgan-lost-its-neutral-rating/ 2018-01-02T13:21:52+00:00 https://diabetespumps.com/new-york-illumina-nasdaqilmn-stock-rating-upgraded-to-outperform-by-analysts-at-wells-fargo-lost-its-market-perform-rating/ 2018-01-02T13:22:15+00:00 https://diabetespumps.com/will-morgan-stanley-upgrade-to-overweight-from-equal-weight-be-a-tailwind-for-haemonetics-hae-stock-today/ 2018-01-02T13:22:31+00:00 https://diabetespumps.com/greif-gef-wins-buy-rating-for-neutral-from-bofa-merrill/ 2018-01-02T13:22:46+00:00 https://diabetespumps.com/globus-medical-gmed-rating-outlook-upped-to-overweight-by-analysts-at-morgan-stanley-from-equal-weight/ 2018-01-02T13:23:01+00:00 https://diabetespumps.com/genesco-gco-rating-was-increased-by-analysts-at-jefferies-to-a-buy-rating/ 2018-01-02T13:23:16+00:00 https://diabetespumps.com/easyjet-otcmktsesyjy-wins-neutral-rating-for-underperform-from-bofa-merrill/ 2018-01-02T13:23:32+00:00 https://diabetespumps.com/discovery-disca-stock-rating-improved-by-analysts-at-macquarie-to-outperform/ 2018-01-02T13:23:46+00:00 https://diabetespumps.com/criteo-crto-rating-upgraded-at-macquarie-to-outperform/ 2018-01-02T13:24:01+00:00 https://diabetespumps.com/how-will-bt-group-plc-bt-stock-react-to-bofa-merrills-upgrade-to-buy-from-neutral/ 2018-01-02T13:24:18+00:00 https://diabetespumps.com/brady-brc-upgraded-by-analysts-at-bofa-merrill-to-underperform-from-underperform-rating/ 2018-01-02T13:24:32+00:00 https://diabetespumps.com/bofa-merrill-upgrades-baxter-bax-rating-to-buy-from-neutral/ 2018-01-02T13:24:48+00:00 https://diabetespumps.com/equity-analysts-at-jpmorgan-increased-baxter-bax-from-neutral-to-overweight-rating/ 2018-01-02T13:24:52+00:00 https://diabetespumps.com/astec-industries-aste-outperform-rating-by-analysts-at-william-blair-from-mkt-perform/ 2018-01-02T13:25:07+00:00 https://diabetespumps.com/will-morgan-stanley-upgrade-to-overweight-from-equal-weight-be-a-tailwind-for-abbott-labs-abt-stock-today/ 2018-01-02T13:25:23+00:00 https://diabetespumps.com/abbott-labs-abt-was-increased-by-analysts-at-jpmorgan-from-a-neutral-rating-to-overweight/ 2018-01-02T13:25:27+00:00 https://diabetespumps.com/netflix-nasdaqnflx-buy-rating-kept-at-loop-capital-the-tp-given-is-241-0/ 2018-01-02T13:25:38+00:00 https://diabetespumps.com/analysts-at-keybanc-reconfirmed-their-underweight-rating-for-sprint-nyses-with-5-0-pt/ 2018-01-02T13:25:44+00:00 https://diabetespumps.com/jefferies-started-coverage-on-odonate-therapeutics-odt-stock-with-40-0-pt/ 2018-01-02T13:25:50+00:00 https://diabetespumps.com/jpmorgan-initiates-coverage-on-denali-therapeutics-nasdaqdnli-with-overweight-and-with-24-0-target/ 2018-01-02T13:25:59+00:00 https://diabetespumps.com/octafinance-looks-at-why-the-analysts-at-jefferies-started-coverage-on-curo-group-nysecuro-with-buy-rating-and-price-target-of-19-0/ 2018-01-02T13:26:08+00:00 https://diabetespumps.com/windstream-nasdaqwin-lowered-to-underweight-rating-by-analysts-at-jpmorgan-from-neutral/ 2018-01-02T13:26:14+00:00 https://diabetespumps.com/edwards-lifesciences-nyseew-was-cut-by-jpmorgan-from-a-overweight-rating-to-neutral-rating/ 2018-01-02T13:26:30+00:00 https://diabetespumps.com/raymond-james-downgrades-cabot-oil-gas-cog-to-underperform-from-outperform-rating/ 2018-01-02T13:26:35+00:00 https://diabetespumps.com/analysts-at-macquarie-improved-netflix-nasdaqnflx-from-neutral-to-outperform-rating/ 2018-01-02T13:26:48+00:00 https://diabetespumps.com/new-york-lincoln-national-nyselnc-rating-upped-to-overweight-at-jpmorgan-lost-its-neutral-rating/ 2018-01-02T13:26:54+00:00 https://diabetespumps.com/easyjet-esyjy-was-improved-at-bofa-merrill-from-a-underperform-rating-to-neutral/ 2018-01-02T13:27:02+00:00 https://diabetespumps.com/amc-networks-nasdaqamcx-was-cut-at-macquarie-from-a-outperform-rating-to-neutral/ 2018-01-02T15:03:13+00:00 https://diabetespumps.com/equity-research-analysts-at-wells-fargo-upgraded-illumina-ilmn-from-market-perform-to-outperform-rating/ 2018-01-02T15:03:27+00:00 https://diabetespumps.com/discovery-nasdaqdisca-rating-increased-at-macquarie-to-outperform/ 2018-01-02T15:03:34+00:00 https://diabetespumps.com/telsey-advisory-reconfirms-a-outperform-rating-on-american-eagle-aeo-and-22-0-target/ 2018-01-02T15:03:57+00:00 https://diabetespumps.com/btig-kept-mcdonalds-nysemcd-as-buy-has-pt-of-200-0/ 2018-01-02T15:04:01+00:00 https://diabetespumps.com/professional-analysts-at-stifel-reconfirmed-their-hold-rating-for-lamb-weston-nyselw-the-price-target-is-set-to-58-0/ 2018-01-02T15:04:08+00:00 https://diabetespumps.com/equity-analysts-at-jpmorgan-decreased-endologix-nasdaqelgx-from-neutral-to-underweight-rating/ 2018-01-02T15:04:37+00:00 https://diabetespumps.com/how-will-globus-medical-nasdaqgmed-stock-react-to-morgan-stanleys-upgrade-to-overweight-from-equal-weight/ 2018-01-02T15:04:59+00:00 https://diabetespumps.com/jpmorgan-increases-abbott-labs-nyseabt-rating-to-overweight-from-neutral/ 2018-01-02T15:05:10+00:00 https://diabetespumps.com/50-74-to-target-telsey-advisory-reiterates-outperform-rating-for-the-childrens-place-plce-stock/ 2018-01-02T15:05:27+00:00 https://diabetespumps.com/lululemon-athletica-lulu-stock-rating-kept-by-analysts-at-telsey-advisory-the-92-0-target-indicates-49-57-potential/ 2018-01-02T15:05:34+00:00 https://diabetespumps.com/l-brands-lb-investors-telsey-advisory-maintains-outperform-rating-sees-70-0-share/ 2018-01-02T15:05:37+00:00 https://diabetespumps.com/urban-outfitters-nasdaqurbn-stock-rating-reiterated-at-telsey-advisory-the-38-0-target-indicates-54-98-potential/ 2018-01-02T15:05:53+00:00 https://diabetespumps.com/timken-nysetkr-wins-buy-rating-for-neutral-from-longbow-research/ 2018-01-02T15:06:31+00:00 https://diabetespumps.com/deutsche-bank-improves-asos-otcmktsasomf-to-buy-from-hold-rating/ 2018-01-02T15:06:51+00:00 https://diabetespumps.com/urban-outfitters-urbn-market-perform-rating-reiterated-at-telsey-advisory-with-38-0-target/ 2018-01-02T15:07:01+00:00 https://diabetespumps.com/equity-analysts-at-credit-suisse-initiated-coverage-of-curo-group-nysecuro-with-a-outperform-rating-the-target-price-per-share-is-set-to-21-0/ 2018-01-02T15:07:19+00:00 https://diabetespumps.com/bitauto-holdings-nysebita-coverage-started-at-citigroup-with-buy-rating/ 2018-01-02T15:07:25+00:00 https://diabetespumps.com/viacom-nasdaqviab-stock-decreased-to-underperform-by-analysts-at-macquarie-from-neutral/ 2018-01-02T15:07:31+00:00 https://diabetespumps.com/how-will-intl-paper-nyseip-stock-react-to-bofa-merrills-upgrade-to-buy-from-neutral/ 2018-01-02T15:07:59+00:00 https://diabetespumps.com/macquarie-ups-criteo-nasdaqcrto-to-outperform-from-neutral-stock-rating/ 2018-01-02T15:08:09+00:00 https://diabetespumps.com/analysts-at-barclays-reiterate-their-overweight-rating-for-ally-financial-ally-the-target-is-set-to-36-0/ 2018-01-02T17:02:46+00:00 https://diabetespumps.com/fgl-holdings-cvefg-is-now-covered-by-equity-research-analysts-at-jpmorgan-they-set-a-neutral-rating-on-the-stock/ 2018-01-02T17:03:21+00:00 https://diabetespumps.com/greif-nysegef-increased-by-analysts-at-bofa-merrill-to-a-buy-rating/ 2018-01-02T17:03:58+00:00 https://diabetespumps.com/globus-medical-nysegmed-increased-by-analysts-at-morgan-stanley-to-equal-weight-from-equal-weight-rating/ 2018-01-02T17:04:02+00:00 https://diabetespumps.com/equity-analysts-at-barclays-reconfirmed-their-underweight-rating-for-regions-fincl-rf-the-pt-is-19-0/ 2018-01-02T17:04:27+00:00 https://diabetespumps.com/jpmorgan-chase-jpm-stock-rating-reaffirmed-by-analysts-at-barclays-the-132-0-target-indicates-31-20-potential/ 2018-01-02T17:04:42+00:00 https://diabetespumps.com/bank-of-america-bac-investors-barclays-reconfirms-equal-weight-rating-sees-35-0-share/ 2018-01-02T17:05:09+00:00 https://diabetespumps.com/comerica-cma-stock-rating-maintained-by-analysts-at-barclays-the-93-0-target-indicates-18-37-potential/ 2018-01-02T17:05:24+00:00 https://diabetespumps.com/citigroup-c-overweight-rating-maintained-at-barclays-with-93-0-target/ 2018-01-02T17:05:38+00:00 https://diabetespumps.com/barclays-reconfirmed-huntington-banc-nasdaqhban-as-equal-weight-has-pt-of-17-0/ 2018-01-02T17:05:57+00:00 https://diabetespumps.com/eu-keycorp-keys-stock-had-its-underweight-rating-restated-at-barclays-in-report-issued-today-has-23-0-target/ 2018-01-02T17:06:12+00:00 https://diabetespumps.com/barclays-maintains-a-equal-weight-rating-on-pnc-pnc-and-168-0-target/ 2018-01-02T17:06:27+00:00 https://diabetespumps.com/bny-mellon-bk-stock-overweight-rating-kept-at-barclays-the-price-target-is-set-to-66-0/ 2018-01-02T17:06:43+00:00 https://diabetespumps.com/eu-citizens-financial-group-cfgs-stock-had-its-equal-weight-rating-restated-at-barclays-in-report-issued-today-has-49-0-target/ 2018-01-02T17:06:58+00:00 https://diabetespumps.com/barclays-reaffirms-62-0-price-objective-on-morgan-stanley-ms-reaffirms-equal-weight-rating/ 2018-01-02T17:07:13+00:00 https://diabetespumps.com/barclays-keeps-texas-capital-tcbi-as-equal-weight-has-target-price-per-share-of-103-0/ 2018-01-02T17:07:27+00:00 https://diabetespumps.com/analysts-at-barclays-reiterate-their-equal-weight-rating-for-goldman-sachs-gs-with-308-0-price-target/ 2018-01-02T17:07:42+00:00 https://diabetespumps.com/mt-bank-mtb-overweight-rating-kept-by-barclays-with-205-0-target/ 2018-01-02T17:07:58+00:00 https://diabetespumps.com/barclays-reconfirms-svb-financial-group-sivb-as-equal-weight-has-pt-of-251-0/ 2018-01-02T17:08:14+00:00 https://diabetespumps.com/barclays-reiterates-75-0-price-objective-on-wells-fargo-wfc-reiterates-overweight-rating/ 2018-01-02T17:08:29+00:00 https://diabetespumps.com/eu-state-street-stts-stock-had-its-overweight-rating-restated-at-barclays-in-report-issued-today-has-120-0-target/ 2018-01-02T17:08:44+00:00 https://diabetespumps.com/barclays-reconfirms-120-0-tp-on-capital-one-cof-reconfirms-overweight-rating/ 2018-01-02T17:08:59+00:00 https://diabetespumps.com/suntrust-banks-sti-stock-rating-maintained-by-barclays-the-77-0-target-indicates-27-89-potential/ 2018-01-02T17:09:15+00:00 https://diabetespumps.com/eu-fifth-third-fitbs-stock-had-its-equal-weight-rating-restated-at-barclays-in-report-issued-today-has-35-0-target/ 2018-01-02T17:09:29+00:00 https://diabetespumps.com/first-hawaiian-fhb-stock-rating-reconfirmed-by-barclays-the-36-0-target-indicates-23-12-potential/ 2018-01-02T17:09:44+00:00 https://diabetespumps.com/northern-trust-ntrs-stock-rating-maintained-at-barclays-the-114-0-target-indicates-21-90-potential/ 2018-01-02T17:09:59+00:00 https://diabetespumps.com/eu-bbt-corp-bbts-stock-had-its-equal-weight-rating-restated-at-barclays-in-report-issued-today-has-57-0-target/ 2018-01-02T17:10:15+00:00 https://diabetespumps.com/peoples-united-financial-pbct-investors-barclays-maintains-underweight-rating-sees-20-0-share/ 2018-01-02T17:10:30+00:00 https://diabetespumps.com/first-financial-ffbc-underweight-rating-kept-by-barclays-the-target-price-per-share-is-set-to-30-0/ 2018-01-02T17:10:44+00:00 https://diabetespumps.com/barclays-analyst-reaffirmed-22-0-price-target-on-umpqua-holdings-umpq-stock-while-reiterating-equal-weight-rating/ 2018-01-02T17:11:00+00:00 https://diabetespumps.com/prosperity-bancshares-nysepb-investors-barclays-keeps-overweight-rating-sees-79-0-share/ 2018-01-02T17:11:05+00:00 https://diabetespumps.com/zions-bancorp-zion-stock-overweight-rating-kept-at-barclays-the-price-objective-is-57-0/ 2018-01-02T17:11:20+00:00 https://diabetespumps.com/barclays-kept-tcf-financial-tcf-as-overweight-has-tp-of-23-0/ 2018-01-02T17:11:36+00:00 https://diabetespumps.com/first-horizon-fhn-investors-barclays-reconfirms-equal-weight-rating-sees-23-0-share/ 2018-01-02T17:11:52+00:00 https://diabetespumps.com/first-interstate-bancsystem-fibk-stock-rating-reaffirmed-at-barclays-the-47-0-target-indicates-19-59-potential/ 2018-01-02T17:12:08+00:00 https://diabetespumps.com/19-53-to-target-barclays-reiterates-overweight-rating-for-u-s-bancorp-usb-stock/ 2018-01-02T17:12:24+00:00 https://diabetespumps.com/new-york-community-nycb-stock-rating-reconfirmed-by-barclays-the-13-0-target-indicates-3-50-potential/ 2018-01-02T17:12:40+00:00 https://diabetespumps.com/bank-of-hawaii-boh-equal-weight-rating-reconfirmed-by-analysts-at-barclays-the-target-price-is-92-0/ 2018-01-02T17:12:54+00:00 https://diabetespumps.com/barclays-analyst-reaffirmed-53-0-price-target-on-synovus-snv-stock-while-reiterating-equal-weight-rating/ 2018-01-02T17:13:09+00:00 https://diabetespumps.com/signature-bank-sbny-stock-rating-kept-by-barclays-the-151-0-target-indicates-16-14-potential/ 2018-01-02T17:13:23+00:00 https://diabetespumps.com/assoc-banc-corp-asb-stock-rating-reconfirmed-by-analysts-at-barclays-the-29-0-target-indicates-14-62-potential/ 2018-01-02T17:13:37+00:00 https://diabetespumps.com/webster-financial-wbs-stock-overweight-rating-maintained-at-barclays-the-pt-given-is-59-0/ 2018-01-02T17:13:52+00:00 https://diabetespumps.com/commerce-bancshares-cbsh-equal-weight-rating-kept-by-barclays-the-target-price-per-share-given-is-59-0/ 2018-01-02T17:14:08+00:00 https://diabetespumps.com/barclays-reaffirms-15-0-target-price-per-share-on-investors-bancorp-isbc-reaffirms-underweight-rating/ 2018-01-02T17:14:23+00:00 https://diabetespumps.com/barclays-analyst-reaffirmed-46-0-price-target-on-bankunited-bku-stock-while-reiterating-overweight-rating/ 2018-01-02T17:14:37+00:00 https://diabetespumps.com/research-analysts-at-barclays-kept-their-overweight-rating-for-western-alliance-bancorp-wal-the-pt-is-set-to-69-0/ 2018-01-02T17:14:53+00:00 https://diabetespumps.com/barclays-keeps-a-overweight-rating-on-east-west-banc-ewbc-and-70-0-target/ 2018-01-02T17:15:07+00:00 https://diabetespumps.com/barclays-reaffirms-a-underweight-rating-on-fulton-fincl-fult-and-19-0-target/ 2018-01-02T17:15:22+00:00 https://diabetespumps.com/barclays-reconfirms-22-0-price-target-on-dime-community-dcom-reconfirms-underweight-rating/ 2018-01-02T17:15:36+00:00 https://diabetespumps.com/eu-cullen-frost-cfrs-stock-had-its-equal-weight-rating-restated-at-barclays-in-report-issued-today-has-110-0-target/ 2018-01-02T17:15:51+00:00 https://diabetespumps.com/barclays-reconfirms-first-republic-bank-frc-as-equal-weight-has-tp-of-101-0/ 2018-01-02T17:16:06+00:00 https://diabetespumps.com/eu-netease-ntess-stock-had-its-equal-weight-rating-restated-at-barclays-in-report-issued-today-has-315-0-target/ 2018-01-02T17:16:22+00:00 https://diabetespumps.com/analysts-at-rbc-capital-decreased-enanta-pharmaceuticals-nasdaqenta-from-outperform-to-sector-perform-rating/ 2018-01-02T17:17:14+00:00 https://diabetespumps.com/mt-bank-nysemtb-stock-overweight-rating-maintained-at-barclays-the-price-objective-given-is-205-0/ 2018-01-02T17:17:29+00:00 https://diabetespumps.com/dunkin-brands-nasdaqdnkn-buy-rating-maintained-at-maxim-group-with-71-0-target/ 2018-01-02T17:17:41+00:00 https://diabetespumps.com/prosperity-bancshares-pb-overweight-rating-reconfirmed-at-barclays-the-target-is-79-0/ 2018-01-02T17:17:45+00:00 https://diabetespumps.com/new-york-community-nysenycb-stock-equal-weight-rating-reaffirmed-at-barclays-the-price-objective-is-13-0/ 2018-01-02T17:17:55+00:00 https://diabetespumps.com/barclays-analyst-reaffirmed-59-0-price-target-on-commerce-bancshares-nasdaqcbsh-stock-while-reiterating-equal-weight-rating/ 2018-01-02T17:18:02+00:00 https://diabetespumps.com/how-will-petrochina-nyseptr-stock-react-to-morgan-stanleys-downgrade-to-equal-weight-from-overweight/ 2018-01-02T17:18:30+00:00 https://diabetespumps.com/plantronics-nyseplt-was-upped-by-analysts-at-sidoti-to-a-buy-rating/ 2018-01-02T17:18:50+00:00 https://diabetespumps.com/investors-bancorp-nasdaqisbc-underweight-rating-reiterated-by-analysts-at-barclays-with-15-0-target/ 2018-01-02T17:19:35+00:00 https://diabetespumps.com/planet-fitness-plnt-stock-downgraded-by-analysts-at-jefferies-to-hold/ 2018-01-02T17:20:01+00:00 https://diabetespumps.com/eu-intl-consolidated-airlines-otcmktsicagy-stock-rating-upped-to-buy-by-analysts-at-bofa-merrill-lost-its-underperform-rating/ 2018-01-02T17:20:27+00:00 https://diabetespumps.com/xpo-logistics-nysexpo-buy-rating-kept-by-stifel-nicolaus-the-target-is-120-00/ 2018-01-02T18:58:18+00:00 https://diabetespumps.com/equity-analysts-at-jp-morgan-cut-windstream-holdings-win-nysewin-from-neutral-to-underweight-rating/ 2018-01-02T18:58:24+00:00 https://diabetespumps.com/eu-viacom-inc-ndaqviab-rating-outlook-decreased-to-underperform-at-macquarie-research-lost-its-neutral-rating/ 2018-01-02T18:58:30+00:00 https://diabetespumps.com/equity-research-analysts-at-keybanc-capital-markets-kept-the-same-their-sector-weight-rating-for-verizon-communications-inc-nysevz-the-target-price-is-53-00/ 2018-01-02T18:58:35+00:00 https://diabetespumps.com/will-guggenheim-downgrade-to-neutral-from-buy-be-a-headwind-for-vectren-corporation-nysevvc-stock-today/ 2018-01-02T18:58:41+00:00 https://diabetespumps.com/ladenburg-thalmann-initiates-coverage-on-urogen-pharma-ndaqurgn-stock-with-buy-rating-and-50-00-target/ 2018-01-02T18:58:46+00:00 https://diabetespumps.com/urban-outfitters-inc-ndaqurbn-market-perform-rating-reaffirmed-at-telsey-advisory-group-with-38-00-target/ 2018-01-02T18:58:54+00:00 https://diabetespumps.com/will-william-blair-upgrade-to-mkt-perform-from-underperform-be-a-tailwind-for-titan-machinery-nysetitn-stock-today/ 2018-01-02T18:58:59+00:00 https://diabetespumps.com/analysts-at-macquarie-research-upgraded-the-walt-disney-company-nysedis-from-neutral-to-outperform-rating/ 2018-01-02T18:59:04+00:00 https://diabetespumps.com/the-allstate-corporation-nyseall-was-cut-at-kbw-from-a-mkt-perform-rating-to-underperform-one/ 2018-01-02T18:59:10+00:00 https://diabetespumps.com/teradyne-inc-nyseter-rating-was-increased-by-analysts-at-evercore-isi-to-a-outperform-rating/ 2018-01-02T18:59:15+00:00 https://diabetespumps.com/taylor-morrison-home-corporation-nysetmhc-stock-rating-upped-at-citigroup-to-buy/ 2018-01-02T18:59:20+00:00 https://diabetespumps.com/leerink-swann-decreases-sucampo-pharmaceuticals-nysescmp-rating-to-mkt-perform-from-outperform/ 2018-01-02T18:59:26+00:00 https://diabetespumps.com/stryker-corporation-nysesyk-given-the-better-overweight-rating-by-analysts-at-jp-morgan-no-longer-has-neutral-rating/ 2018-01-02T18:59:31+00:00 https://diabetespumps.com/new-york-statoil-asa-nysesto-rating-outlook-upgraded-to-outperform-by-rbc-capital-markets-lost-its-sector-perform-rating/ 2018-01-02T18:59:36+00:00 https://diabetespumps.com/smart-sand-snd-nysesnd-lowered-by-janney-capital-to-neutral-from-buy-rating/ 2018-01-02T18:59:42+00:00 https://diabetespumps.com/sirius-xm-holdings-ndaqsiri-stock-lowered-at-jp-morgan-to-underweight/ 2018-01-02T18:59:47+00:00 https://diabetespumps.com/bank-of-america-merrill-lynch-decreases-silgan-holdings-inc-ndaqslgn-rating-to-underperform-from-neutral/ 2018-01-02T18:59:53+00:00 https://diabetespumps.com/bernstein-decreases-royal-bank-of-scotland-group-plc-adr-nyserbs-rating-to-mkt-perform-from-outperform/ 2018-01-02T18:59:58+00:00 https://diabetespumps.com/how-will-quanterix-unknownqtrx-stock-react-to-leerink-swann-new-ratings-coverage-and-27-00-price-target/ 2018-01-02T19:00:05+00:00 https://diabetespumps.com/quanterix-unknownqtrx-coverage-initiated-by-analysts-at-jp-morgan-with-overweight-rating/ 2018-01-02T19:00:11+00:00 https://diabetespumps.com/analysts-at-hovde-group-downgraded-prosperity-bancshares-nysepb-from-market-perform-to-underperform-the-target-price-is-68-00/ 2018-01-02T19:00:16+00:00 https://diabetespumps.com/progress-software-corporation-ndaqprgs-stock-rating-maintained-by-benchmark-the-47-00-target-indicates-85-48-potential/ 2018-01-02T19:00:22+00:00 https://diabetespumps.com/potlatch-corporation-ndaqpch-was-upped-by-bank-of-america-merrill-lynch-from-a-underperform-rating-to-neutral-rating/ 2018-01-02T19:00:27+00:00 https://diabetespumps.com/will-goldman-sachs-upgrade-to-buy-from-neutral-be-a-tailwind-for-posco-nysepkx-stock-today/ 2018-01-02T19:00:32+00:00 https://diabetespumps.com/will-guggenheim-downgrade-to-sell-from-neutral-be-a-headwind-for-pge-corporation-nysepcg-stock-today/ 2018-01-02T19:00:37+00:00 https://diabetespumps.com/pge-corporation-nysepcg-downgraded-at-goldman-sachs-to-neutral-from-buy-rating/ 2018-01-02T19:00:41+00:00 https://diabetespumps.com/jp-morgan-decreases-penumbra-nysepen-to-neutral-from-overweight-rating/ 2018-01-02T19:00:46+00:00 https://diabetespumps.com/professional-analysts-at-bank-of-america-merrill-lynch-upped-paccar-inc-ndaqpcar-from-neutral-to-buy-rating/ 2018-01-02T19:00:51+00:00 https://diabetespumps.com/omnicom-group-inc-nyseomc-given-a-underperform-rating-by-analysts-at-macquarie-research-lost-its-neutral-rating/ 2018-01-02T19:00:57+00:00 https://diabetespumps.com/will-jefferies-co-new-ratings-coverage-and-40-00-target-help-odonate-therapeutics-unknownodt-stock-today/ 2018-01-02T19:01:04+00:00 https://diabetespumps.com/odonate-therapeutics-unknownodt-stock-goldman-sachs-initiates-coverage-with-neutral-rating-outlook/ 2018-01-02T19:01:10+00:00 https://diabetespumps.com/how-will-nrg-yield-inc-nysenyld-stock-react-to-guggenheims-upgrade-to-buy-from-neutral/ 2018-01-02T19:01:15+00:00 https://diabetespumps.com/north-west-natural-gas-company-nysenwn-decreased-by-guggenheim-to-sell-from-neutral-rating/ 2018-01-02T19:01:20+00:00 https://diabetespumps.com/will-jp-morgan-upgrade-to-neutral-from-underweight-be-a-tailwind-for-nordstrom-inc-nysejwn-stock-today/ 2018-01-02T19:01:25+00:00 https://diabetespumps.com/macquarie-research-reduces-nielsen-holdings-nv-nysenlsn-rating-to-neutral-from-outperform/ 2018-01-02T19:01:30+00:00 https://diabetespumps.com/guggenheim-begin-coverage-coverage-on-nextera-energy-partners-nysenep-stock-with-45-00-tp/ 2018-01-02T19:01:35+00:00 https://diabetespumps.com/will-macquarie-research-upgrade-to-outperform-from-neutral-be-a-tailwind-for-netflix-inc-ndaqnflx-stock-today/ 2018-01-02T19:01:42+00:00 https://diabetespumps.com/loop-capital-reconfirms-241-00-price-objective-on-netflix-inc-ndaqnflx-reconfirms-buy-rating/ 2018-01-02T19:01:49+00:00 https://diabetespumps.com/how-will-national-fuel-gas-co-nysenfg-stock-react-to-sidotis-upgrade-to-buy-from-neutral/ 2018-01-02T19:01:54+00:00 https://diabetespumps.com/eu-merus-labs-international-ndaqmrus-stock-rating-cut-to-sector-perform-by-rbc-capital-markets-lost-its-outperform-rating/ 2018-01-02T19:02:01+00:00 https://diabetespumps.com/bank-of-america-merrill-lynch-upgrades-medtronic-inc-nysemdt-to-buy-from-neutral-rating/ 2018-01-02T19:02:07+00:00 https://diabetespumps.com/luther-burbank-unknownlbc-is-now-covered-by-analysts-at-sandler-oneill-and-got-hold-rating/ 2018-01-02T19:02:14+00:00 https://diabetespumps.com/luther-burbank-unknownlbc-receives-new-coverage-at-piper-jaffray-and-has-14-00-target-price-per-share/ 2018-01-02T19:02:19+00:00 https://diabetespumps.com/will-kbw-new-ratings-coverage-help-luther-burbank-unknownlbc-stock-today/ 2018-01-02T19:02:24+00:00 https://diabetespumps.com/lululemon-athletica-inc-ndaqlulu-outperform-rating-maintained-at-telsey-advisory-group-with-92-00-target/ 2018-01-02T19:02:30+00:00 https://diabetespumps.com/eu-lululemon-athletica-inc-ndaqlulu-stock-rating-cut-to-neutral-by-analysts-at-citigroup-lost-its-buy-rating/ 2018-01-02T19:02:35+00:00 https://diabetespumps.com/wells-fargo-ups-lennar-corporation-nyselen-rating-to-outperform-from-market-perform/ 2018-01-02T19:02:40+00:00 https://diabetespumps.com/l-brands-inc-nyselb-stock-rating-maintained-by-telsey-advisory-group-the-70-00-target-indicates-7-28-potential/ 2018-01-02T19:02:46+00:00 https://diabetespumps.com/robert-w-baird-increases-l-brands-inc-nyselb-rating-to-outperform-from-neutral-keeping-70-00-target-price-per-share/ 2018-01-02T19:02:50+00:00 https://diabetespumps.com/kb-home-nysekbh-rating-decreased-to-sell-by-citigroup-from-neutral/ 2018-01-02T19:02:54+00:00 https://diabetespumps.com/juniper-pharmaceuticals-inc-ndaqjnp-buy-rating-maintained-by-analysts-at-roth-capital-the-price-target-given-is-12-00/ 2018-01-02T19:03:12+00:00 https://diabetespumps.com/equity-analysts-at-suntrust-robinson-downgraded-jones-energy-inc-nysejone-from-buy-to-hold-rating/ 2018-01-02T19:03:17+00:00 https://diabetespumps.com/johnson-johnson-nysejnj-was-lowered-by-analysts-at-jp-morgan-from-a-overweight-rating-to-neutral-rating/ 2018-01-02T19:03:24+00:00 https://diabetespumps.com/intersect-ent-ndaqxent-was-upgraded-at-jp-morgan-from-a-neutral-rating-to-overweight-one/ 2018-01-02T19:03:30+00:00 https://diabetespumps.com/macquarie-research-reduces-interpublic-nyseipg-rating-to-underperform-from-neutral/ 2018-01-02T19:03:35+00:00 https://diabetespumps.com/international-paper-company-nyseip-was-increased-by-bank-of-america-merrill-lynch-from-a-neutral-rating-to-buy-rating/ 2018-01-02T19:03:39+00:00 https://diabetespumps.com/professional-analysts-at-bank-of-america-merrill-lynch-upgraded-international-consolidated-airlines-adr-otcicagy-from-underperform-to-buy-rating/ 2018-01-02T19:03:45+00:00 https://diabetespumps.com/integra-lifesciences-holdings-corp-ndaqiart-rating-downgraded-at-bank-of-america-merrill-lynch-to-neutral/ 2018-01-02T19:03:50+00:00 https://diabetespumps.com/research-analysts-at-rbc-capital-markets-increased-incyte-incy-nyseincy-from-sector-perform-to-outperform-rating/ 2018-01-02T19:03:57+00:00 https://diabetespumps.com/how-will-illumina-inc-ndaqilmn-stock-react-to-wells-fargos-upgrade-to-outperform-from-market-perform/ 2018-01-02T19:04:02+00:00 https://diabetespumps.com/hill-rom-nysehrc-rating-outlook-decreased-at-morgan-stanley-to-equal-weight/ 2018-01-02T19:04:07+00:00 https://diabetespumps.com/haemonetics-corporation-nysehae-improved-by-morgan-stanley-to-equal-weight-from-equal-weight-rating/ 2018-01-02T19:04:12+00:00 https://diabetespumps.com/greif-inc-nysegef-rating-upgraded-to-buy-by-bank-of-america-merrill-lynch-from-neutral/ 2018-01-02T19:04:16+00:00 https://diabetespumps.com/genesco-nysegco-stock-rating-upped-by-analysts-at-jefferies-co-to-buy/ 2018-01-02T19:04:21+00:00 https://diabetespumps.com/jp-morgan-starts-fgl-holdings-unknownfg-coverage-with-neutral-rating/ 2018-01-02T19:04:28+00:00